Psilocybin Clinical Trials
127 record(s) found.
Entheogen: psilocybinStudy Title: Psilocybin-assisted CBT for DepressionStart Date: Jan 01, 2023 - Last Update: July 25, 2022Conditions: Major Depressive DisorderLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects of Repeated Psilocybin Dosing in OCDStart Date: Nov 01, 2022 - Last Update: June 9, 2022Conditions: Obsessive-Compulsive DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin Therapy in Advanced CancerStart Date: Nov 01, 2022 - Last Update: June 1, 2022Conditions: Advanced CancerLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin-assisted Psychotherapy for Treatment of Alcohol Use DisorderStart Date: Nov 01, 2022 - Last Update: July 21, 2022Conditions: Alcohol Use DisorderLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Pragmatic Trial of Psilocybin Therapy in Palliative CareStart Date: Oct 01, 2022 - Last Update: June 3, 2022Conditions: DemoralizationLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin-assisted Therapy for Treatment of Alcohol Use DisorderStart Date: Oct 01, 2022 - Last Update: June 13, 2022Conditions: Alcohol Use DisorderLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Bioavailability Study of Psilocybin in Normal AdultsStart Date: Oct 01, 2022 - Last Update: July 20, 2022Conditions: HealthyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the BrainStart Date: Oct 01, 2022 - Last Update: July 29, 2022Conditions: Perception DisordersLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in AdultsStart Date: Sep 15, 2022 - Last Update: June 30, 2022Conditions: Anxiety and DepressionLocation(s): JamaicaSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress DisorderStart Date: Sep 01, 2022 - Last Update: July 29, 2022Conditions: Treatment Resistant Disorders, Post Traumatic Stress DisorderLocation(s): CanadaSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use DisorderStart Date: Sep 01, 2022 - Last Update: July 19, 2022Conditions: Methamphetamine Use Disorder, Substance-Related Disorders, Chemically-Induced Disorders, Substance Use Disorders, Stimulant-Use DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Palliadelic Treatment to Reduce Psychological Distress in Persons With Inoperable Pancreatobiliary CancerStart Date: Sep 01, 2022 - Last Update: June 22, 2022Conditions: Pancreas Cancer, Biliary Tract Cancer, Psychological DistressLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality DisorderStart Date: Sep 01, 2022 - Last Update: June 1, 2022Conditions: Borderline Personality Disorder, Major Depressive DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over StudyStart Date: Sep 01, 2022 - Last Update: May 20, 2022Conditions: HealthyLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyStart Date: Aug 01, 2022 - Last Update: August 1, 2022Conditions: Anorexia NervosaLocation(s): United States, United KingdomSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin-facilitated Treatment for Chronic PainStart Date: Aug 01, 2022 - Last Update: May 13, 2022Conditions: Fibromyalgia, PrimaryLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Exploratory Study of Low Dose PsilocybinStart Date: Aug 01, 2022 - Last Update: May 13, 2022Conditions: DemoralizationLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderStart Date: Aug 01, 2022 - Last Update: July 11, 2022Conditions: Tobacco Use DisorderLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin-Enhanced Psychotherapy for Methamphetamine Use DisorderStart Date: Jul 07, 2022 - Last Update: July 14, 2022Conditions: Amphetamine-Related DisordersLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: A Study of a Psilocybin Analog (CYB003) in Participants With Major Depressive DisorderStart Date: Jul 06, 2022 - Last Update: July 13, 2022Conditions: Major Depressive DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderStart Date: Jul 01, 2022 - Last Update: July 21, 2022Conditions: Post Traumatic Stress DisorderLocation(s): United States, United KingdomSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Ketamine-Assisted PsychoTherapy ViAbility in Treating Cancer-related Emotional DistressStart Date: Jul 01, 2022 - Last Update: April 25, 2022Conditions: Cancer-related Problem/Condition, Depressive Symptoms, Anxiety DisordersLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: ELE-101 Safety & Tolerability Study in Healthy ParticipantsStart Date: Jul 01, 2022 - Last Update: July 15, 2022Conditions: Healthy VolunteersLocation(s): United KingdomSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects of Psilocybin in Post-Treatment Lyme DiseaseStart Date: Jul 01, 2022 - Last Update: July 12, 2022Conditions: Post-Treatment Lyme Disease, Chronic Lyme Disease, Lyme Disease, ChronicLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid UseStart Date: Jul 01, 2022 - Last Update: June 30, 2022Conditions: Opioid Use DisorderLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility StudyStart Date: Jul 01, 2022 - Last Update: June 2, 2022Conditions: Alcohol Use Disorder (AUD)Location(s): DenmarkSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: An Evaluation of Psilocybin's Effect on Cardiac RepolarizationStart Date: Jun 22, 2022 - Last Update: July 28, 2022Conditions: QTc IntervalLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin Therapy for Chronic Low Back PainStart Date: Jun 01, 2022 - Last Update: May 4, 2022Conditions: Chronic Low-back PainLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDDStart Date: Jun 01, 2022 - Last Update: May 19, 2022Conditions: Treatment-Resistant Major Depressive DisorderLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Comparing the Effects of Psilocin and Psilocybin in Healthy AdultsStart Date: May 26, 2022 - Last Update: June 8, 2022Conditions: HealthyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Northwest Therapies Trauma Psilocybin Study Compassionate Use StudyStart Date: May 03, 2022 - Last Update: March 11, 2022Conditions: Trauma, Nervous SystemLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Mood and Cognitive Effects of Psilocybin in Healthy ParticipantsStart Date: Apr 01, 2022 - Last Update: February 23, 2022Conditions: Mood Disturbance, Mood Change, Sleep Disturbance, Drug Effect, Psychedelic Experiences, Health, Subjective, Psilocin Toxicity, Psilocybin Toxicity, Psilocybin Causing Adverse Effects in Therapeutic Use, AnxietyLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Microdosing Psychedelics to Improve MoodStart Date: Apr 01, 2022 - Last Update: March 29, 2022Conditions: Persistent Depressive Disorder, DysthymiaLocation(s): CanadaSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Personality and Drug Use (PDU)Start Date: Apr 01, 2022 - Last Update: April 29, 2022Conditions: PersonalityLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating DisorderStart Date: Mar 16, 2022 - Last Update: May 4, 2022Conditions: Binge Eating DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice CareStart Date: Mar 09, 2022 - Last Update: May 24, 2022Conditions: Hospice, Psilocybin, Demoralization, Terminal Illness, Cancer-related Problem/Condition, Psychotherapy, Terminal Cancer, Cancer TerminalLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects of Psilocybin on Electrophysiology and the Dynamic Content of ThoughtStart Date: Mar 03, 2022 - Last Update: March 29, 2022Conditions: HealthyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Frontline Clinician Psilocybin StudyStart Date: Mar 03, 2022 - Last Update: July 15, 2022Conditions: Burnout, Caregiver, Burnout, Professional, COVID-19, Depression, Post Traumatic Stress Disorder, Moral InjuryLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Safety and tolerability of psilocybin-assisted physiotherapy in healthy volunteersStart Date: Mar 01, 2022Conditions: Functional neurological disorderLocation(s): AustraliaSource: anzctr.org.aushort summary
Entheogen: psilocybinStudy Title: Open-label Study to Assess the Safety and Efficacy of TRP-8802 With Psychotherapy in Adult Participants With FibromyalgiaStart Date: Mar 01, 2022 - Last Update: November 19, 2021Conditions: FibromyalgiaLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin for Psychological and Existential Distress in Palliative CareStart Date: Mar 01, 2022 - Last Update: November 18, 2021Conditions: Depression, Anxiety, Distress, EmotionalLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects of SERT Inhibition on the Subjective Response to LSD in Healthy SubjectsStart Date: Mar 01, 2022 - Last Update: January 3, 2022Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin-assisted therapy for refractory Functional Neurological DisorderStart Date: Mar 01, 2022Conditions: Functional neurological disorderLocation(s): AustraliaSource: anzctr.org.aushort summary
Entheogen: psilocybinStudy Title: Psilocybin-assisted Therapy for Phantom Limb PainStart Date: Mar 01, 2022 - Last Update: February 4, 2022Conditions: Phantom Limb PainLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: A study to investigate the effects of repeated low doses of psilocybin and ketamine on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action
Start Date: Feb 22, 2022Conditions: Parkinson's disease
Location(s): NetherlandsSource: www.clinicaltrialsregister.eushort summary
Entheogen: psilocybinStudy Title: The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal IdeationStart Date: Feb 04, 2022 - Last Update: February 8, 2022Conditions: Treatment Resistant Depression, Suicidal IdeationLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin Therapy for Depression in Bipolar II DisorderStart Date: Jan 28, 2022 - Last Update: February 1, 2022Conditions: Bipolar II DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCDStart Date: Dec 01, 2021 - Last Update: May 12, 2021Conditions: Obsessive-compulsive DisorderLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin for Treatment-Resistant DepressionStart Date: Nov 19, 2021 - Last Update: March 3, 2022Conditions: Treatment Resistant DepressionLocation(s): CanadaSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer, a randomized double-blind study with the possibility of entering open extension.
Start Date: Sep 22, 2021Conditions: Depressive disorder comorbid with cancer
Location(s): Czech RepublicSource: www.clinicaltrialsregister.eushort summary
Entheogen: psilocybinStudy Title: Visual Surround Suppression and Perceptual Expectation Under PsilocybinStart Date: Aug 30, 2021 - Last Update: February 17, 2022Conditions: Perception Disturbance, Visual Suppression, Psychedelic ExperiencesLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Study of Psilocybin Enhanced Group Psychotherapy in Patients With CancerStart Date: Aug 26, 2021 - Last Update: January 27, 2022Conditions: CancerLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin Therapy for Depression and Anxiety in Parkinson's DiseaseStart Date: Aug 15, 2021 - Last Update: September 5, 2021Conditions: Parkinson Disease, Depression, AnxietyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)Start Date: Aug 11, 2021 - Last Update: April 11, 2022Conditions: Short Lasting Unilateral Neuralgiform Headache AttacksLocation(s): United KingdomSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of ConsciousnessStart Date: Aug 11, 2021 - Last Update: August 18, 2021Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Repeat Dosing of Psilocybin in Migraine HeadacheStart Date: Aug 10, 2021 - Last Update: October 25, 2021Conditions: Migraine HeadacheLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionStart Date: Jun 10, 2021 - Last Update: July 29, 2021Conditions: Treatment-resistant DepressionLocation(s): GermanySource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Precision Functional Brain Mapping in PsilocybinStart Date: Jun 01, 2021 - Last Update: June 21, 2022Conditions: PsilocybinLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin as a Treatment for Anorexia Nervosa: A Pilot StudyStart Date: May 28, 2021 - Last Update: August 25, 2021Conditions: Anorexia NervosaLocation(s): United KingdomSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Pilot RECAP Study in Healthy VolunteersStart Date: May 21, 2021 - Last Update: August 2, 2022Conditions: Psychedelic Experiences, AmnesiaLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Evaluation of Psilocybin in Anorexia Nervosa: Safety and EfficacyStart Date: May 01, 2021 - Last Update: July 25, 2022Conditions: Anorexia NervosaLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin Versus Ketamine in Treatment-Resistant DepressionStart Date: May 01, 2021 - Last Update: May 20, 2022Conditions: Treatment Resistant DepressionLocation(s): CzechiaSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use DisorderStart Date: Apr 14, 2021 - Last Update: April 15, 2022Conditions: Major Depressive Disorder, Alcohol Use DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's DiseaseStart Date: Mar 24, 2021 - Last Update: March 24, 2022Conditions: Depressive Symptoms, Depression, Alzheimer Disease, Mild Cognitive ImpairmentLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.Start Date: Mar 01, 2021 - Last Update: November 1, 2021Conditions: Treatment Resistant DepressionLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)Start Date: Mar 01, 2021 - Last Update: December 21, 2021Conditions: Treatment Resistant DepressionLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Safety and Efficacy of Psilocybin for Body Dysmorphic DisorderStart Date: Feb 26, 2021 - Last Update: August 2, 2022Conditions: Body Dysmorphic DisordersLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use DisorderStart Date: Feb 18, 2021 - Last Update: January 31, 2022Conditions: Alcohol Use DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Naturalistic Study of Microdosing With PsilocybinStart Date: Jan 20, 2021 - Last Update: December 16, 2021Conditions: Cognitive Change, Creativity, Mood Change, SleepLocation(s): ArgentinaSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Adjunctive Effects of Psilocybin and BuprenorphineStart Date: Jan 13, 2021 - Last Update: June 3, 2022Conditions: Opioid Use DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: The Effect of Psilocybin on MDD Symptom Severity and Synaptic DensityStart Date: Jan 01, 2021 - Last Update: April 5, 2022Conditions: Major Depressive Disorder, DepressionLocation(s): SwedenSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial.
Start Date: Dec 16, 2020Conditions: Alcohol Use Disorder
Location(s): DenmarkSource: www.clinicaltrialsregister.eushort summary
Entheogen: psilocybinStudy Title: The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant DepressionStart Date: Sep 15, 2020 - Last Update: January 26, 2022Conditions: Treatment Resistant DepressionLocation(s): United States, IrelandSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive DisorderStart Date: Sep 01, 2020 - Last Update: October 15, 2021Conditions: Major Depressive DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin in Depression Resistant to Standard TreatmentsStart Date: Sep 01, 2020 - Last Update: July 22, 2021Conditions: Treatment Resistant DepressionLocation(s): United KingdomSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: A randomised, placebo controlled trial of psilocybin in treatment resistant depression: A feasibility study
Start Date: Aug 27, 2020Conditions: Major depressive disorder
Location(s): United Kingdom(United Kingdom, -, no, longer, in, EU/EstoniaA)Source: www.clinicaltrialsregister.eushort summary
Entheogen: psilocybinStudy Title: Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)Start Date: Jul 20, 2020 - Last Update: March 3, 2021Conditions: Treatment Resistant DepressionLocation(s): United States, Czechia, Ireland, Netherlands, United KingdomSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin versus ketamine – fast acting antidepressant strategies in treatment-resistant depression
Start Date: Jul 14, 2020Conditions: The study will include 60 patients with pharmaco-resistant depression (30 male, 30 female, aged 18–65). The basic inclusion criterion is the diagnosis of pharmaco-resistant moderate to severe depre...
Location(s): Czech RepublicSource: www.clinicaltrialsregister.eushort summary
Entheogen: psilocybinStudy Title: A multicentre study to assess safety and efficacy of psilocybin in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)
Start Date: Jul 08, 2020Conditions: Treatment-Resistant Depression (P-TRD)
Location(s): Portugal, Czech Republic, Denmark, Netherlands, GermanySource: www.clinicaltrialsregister.eushort summary
Entheogen: psilocybinStudy Title: Characterization of Altered Waking States of Consciousness in Healthy HumansStart Date: Jul 08, 2020 - Last Update: April 29, 2021Conditions: Altered Waking States of Consciousness in Healthy HumansLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive DisorderStart Date: Jun 30, 2020 - Last Update: September 30, 2021Conditions: Major Depressive DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted PatientsStart Date: Jun 08, 2020 - Last Update: May 20, 2022Conditions: Alcohol Use DisorderLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Comparative Acute Effects of LSD, Psilocybin and MescalineStart Date: May 19, 2020 - Last Update: March 31, 2022Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Prophylactic Effects of Psilocybin on Chronic Cluster HeadacheStart Date: Jan 21, 2020 - Last Update: February 21, 2020Conditions: Cluster HeadacheLocation(s): DenmarkSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: The Effect of 3, 4-Methylenedioxymethamphetamine (MDMA)-assisted therapy on Mood and Anxiety symptoms in advanced-stage Cancer StudyStart Date: Jan 06, 2020Conditions: Depression symptoms, Anxiety symptoms, Advanced-stage cancerLocation(s): New ZealandSource: anzctr.org.aushort summary
Entheogen: psilocybinStudy Title: The Canadian Underage Substance Use Prevention TrialStart Date: Dec 01, 2019 - Last Update: December 17, 2019Conditions: Substance Use Disorders, Adolescent Behavior, Adolescent DevelopmentLocation(s): CanadaSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: A Study of Psilocybin for Major Depressive Disorder (MDD)Start Date: Oct 15, 2019 - Last Update: July 19, 2022Conditions: Depressive Disorder, MajorLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin-assisted psychotherapy for the treatment of depression and anxiety associated with life-threatening illnessStart Date: Sep 27, 2019Conditions: Depression in terminal illness (any palliative condition including malignant and non-malignant terminal illnesses), Anxiety in terminal illness (any palliative condition including malignant and non-malignan terminal illnesses)Location(s): AustraliaSource: anzctr.org.aushort summary
Entheogen: psilocybinStudy Title: Effects of Psilocybin in Anorexia NervosaStart Date: Aug 26, 2019 - Last Update: October 26, 2021Conditions: Anorexia NervosaLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy SubjectsStart Date: Jul 04, 2019 - Last Update: December 1, 2020Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: SRC Inhibition as a Potential Target for Parkinson's Disease PsychosisStart Date: Apr 11, 2019 - Last Update: August 13, 2019Conditions: Parkinson Disease PsychosisLocation(s): United KingdomSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects of Psilocybin in Concussion HeadacheStart Date: Mar 28, 2019 - Last Update: July 28, 2022Conditions: Post-Traumatic HeadacheLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Direct Comparison of Altered States of Consciousness Induced by LSD and PsilocybinStart Date: Mar 27, 2019 - Last Update: April 27, 2021Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of ConceptStart Date: Mar 11, 2019 - Last Update: April 29, 2022Conditions: Depressive Disorder, MajorLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionStart Date: Mar 01, 2019 - Last Update: January 26, 2022Conditions: Treatment Resistant DepressionLocation(s): United States, Canada, Czechia, Denmark, Germany, Ireland, Netherlands, Portugal, Spain, United KingdomSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative MechanismsStart Date: Jan 07, 2019 - Last Update: July 31, 2020Conditions: Depressive Disorder, MajorLocation(s): United KingdomSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin for Treatment of Obsessive Compulsive DisorderStart Date: Jan 02, 2019 - Last Update: July 15, 2022Conditions: Obsessive-compulsive Disorder (OCD)Location(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.Start Date: Nov 13, 2018 - Last Update: December 9, 2021Conditions: Obsessive-Compulsive DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin and DepressionStart Date: Sep 01, 2018 - Last Update: December 21, 2017Conditions: Severe DepressionLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms
Start Date: Apr 09, 2018Conditions: Major Depressive Disorder
Location(s): United KingdomSource: www.clinicaltrialsregister.eushort summary
Entheogen: psilocybinStudy Title: Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive DisorderStart Date: Feb 27, 2018 - Last Update: July 20, 2022Conditions: Major Depressive DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS SurvivorsStart Date: Jan 05, 2018 - Last Update: January 7, 2021Conditions: Distress, Depression, GriefLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin for the Treatment of Migraine HeadacheStart Date: Nov 01, 2017 - Last Update: February 25, 2022Conditions: Migraine HeadacheLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects of Psilocybin in Major Depressive DisorderStart Date: Aug 10, 2017 - Last Update: December 15, 2021Conditions: Major Depressive DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Persisting Effects of PsilocybinStart Date: Jul 01, 2017 - Last Update: September 10, 2019Conditions: HealthyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety DisordersStart Date: Jun 23, 2017 - Last Update: December 22, 2021Conditions: Patients, Anxiety DisordersLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin as a tool for enhancing cognitive flexibilityStart Date: May 01, 2017 - Last Update: Conditions: psilocybin, divergent thinking, neurotransmissionLocation(s): NetherlandsSource: trialregister.nlshort summary
Entheogen: psilocybinStudy Title: The Neurobiological Effect of 5-HT2AR ModulationStart Date: Mar 03, 2017 - Last Update: August 13, 2020Conditions: Basic ScienceLocation(s): DenmarkSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin for the Treatment of Cluster HeadacheStart Date: Nov 01, 2016 - Last Update: July 28, 2022Conditions: Cluster HeadacheLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin-facilitated Treatment for Cocaine UseStart Date: May 01, 2015 - Last Update: August 2, 2022Conditions: Cocaine-Related DisordersLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious ProfessionalsStart Date: Apr 01, 2015 - Last Update: February 14, 2022Conditions: Religious or Spiritual ProblemLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in ReligionStart Date: Mar 01, 2015 - Last Update: June 2, 2022Conditions: HealthyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Assessing the subjective intensity of oral psilocybin in patients with treatment-resistant depression: A Pilot Study
Start Date: Jan 07, 2015Conditions: Major depressive disorder
Location(s): United KingdomSource: www.clinicaltrialsregister.eushort summary
Entheogen: psilocybinStudy Title: Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI
Start Date: Jun 18, 2014Conditions: Inclusion criteria:Location(s): Czech RepublicSource: www.clinicaltrialsregister.eushort summary
Entheogen: psilocybinStudy Title: A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceStart Date: Jun 01, 2014 - Last Update: July 5, 2022Conditions: Alcohol DependenceLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: UW Psilocybin Pharmacokinetics StudyStart Date: Jun 01, 2014 - Last Update: April 15, 2020Conditions: HealthyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects of Hallucinogens and Other Drugs on Mood and PerformanceStart Date: Apr 01, 2014 - Last Update: May 16, 2019Conditions: HealthyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the SelfStart Date: Oct 01, 2013 - Last Update: November 4, 2020Conditions: HealthyLocation(s): Source: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsStart Date: May 01, 2013 - Last Update: May 20, 2014Conditions: Psilocybin, Hallucinogens, Pharmacologic Actions, Central Nervous System Agents, Therapeutic Uses, Psychotropic DrugsLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV MelanomaStart Date: Jan 01, 2012 - Last Update: June 16, 2022Conditions: Anxiety, Stage IV MelanomaLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects and Therapeutic Potential of Psilocybin in Alcohol DependenceStart Date: Jan 01, 2012 - Last Update: February 10, 2014Conditions: Alcohol DependenceLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin and Spiritual PracticeStart Date: Aug 01, 2009 - Last Update: February 24, 2016Conditions: HealthyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin Cancer Anxiety StudyStart Date: Feb 01, 2009 - Last Update: October 20, 2020Conditions: CancerLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psilocybin-facilitated Smoking Cessation Treatment: A Pilot StudyStart Date: Sep 01, 2008 - Last Update: October 4, 2021Conditions: Nicotine DependenceLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Psychopharmacology of Psilocybin in Cancer PatientsStart Date: Apr 01, 2007 - Last Update: July 19, 2018Conditions: Depressive Symptoms, Anxiety, CancerLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: Effects of Psilocybin in Advanced-Stage Cancer Patients With AnxietyStart Date: Apr 01, 2004 - Last Update: April 22, 2022Conditions: AnxietyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: psilocybinStudy Title: The safety and efficacy of psilocybin as an adjunctive therapy in participants with treatment-resistant depression
Start Date: Conditions: treatment resistant depression
Location(s): IrelandSource: www.clinicaltrialsregister.eushort summary
Total execution time in seconds: 0.023582935333252